# Career Enhancement Program (CEP)

> **NIH NIH P50** · WEILL MEDICAL COLL OF CORNELL UNIV · 2021 · $97,709

## Abstract

CAREER ENHANCEMENT PROGRAM SUMMARY
The overall Specific Aim of the Career Enhancement Program (CEP) is to 1) recruit and develop the
careers of junior faculty who are committed to translational research in prostate cancer (PCa), and to 2)
identify mid- and senior-level investigators who are already established in another area of research, but
want to redirect their focus to the field of PCa. Building on the already existing outstanding programs and
excellent resources for translational and clinical research in PCa at Weill Cornell Medicine (WCM) and
the Columbia University Medical Center, our CEP is designed to develop future leaders in PCa research.
Using a rigorous grant selection process, our CEP Advisory Committee (AC), will identify candidates with
the highest potential for success and who are committed to careers in PCa research. The AC members
will make recommendations to the WCM SPORE's Executive Committee for funding and then closely
monitor the progress of all awarded investigators to ensure that the Program's goals in research,
education, and scientific and grant writing are met. They will also provide positive research role models in
a supportive academic environment. The ultimate goal of the CEP is to provide awardees with the
knowledge and tools necessary for successful clinical, translational, and/or basic science PCa research
careers. At the conclusion of their involvement with the CEP, awardees will be able to design and conduct
hypothesis-driven PCa research, with significantly increased abilities to obtain peer-reviewed grant
funding from federal or other extramural sources.
Drs. Douglas Scherr and Lorraine Gudas, each of who have extensive experience in mentoring and
developing the career of junior faculty, will oversee the CEP. As part of the CEP, we will also educate and
mentor physicians and laboratory-based scientists in cross collaborations that will lead to the design and
conduct of hypothesis-driven clinical/translational therapeutic research in PCa by creating a collaborative
and productive research setting within the PCa SPORE.

## Key facts

- **NIH application ID:** 10227735
- **Project number:** 5P50CA211024-05
- **Recipient organization:** WEILL MEDICAL COLL OF CORNELL UNIV
- **Principal Investigator:** LORRAINE J GUDAS
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $97,709
- **Award type:** 5
- **Project period:** 2017-08-30 → 2023-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10227735

## Citation

> US National Institutes of Health, RePORTER application 10227735, Career Enhancement Program (CEP) (5P50CA211024-05). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10227735. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*